📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Isconova

1.1 - Company Overview

Isconova Logo

Isconova

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of adjuvants and vaccines, developing and commercializing adjuvants for veterinary and human vaccines to enhance immune reactions with longer duration. Products include Matrix-M, inducing cell- and antibody-mediated immune responses for use in vaccines for humans and dogs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Isconova

Now Diagnostics Logo

Now Diagnostics

HQ: United States Website
  • Description: Provider of rapid, single-drop-of-blood diagnostic tests delivering results within minutes, including ADEXUSDx assays for COVID-19 antibodies, hCG for early pregnancy, syphilis antibodies, elevated acetaminophen, H-FABP for myocardial damage, and methanol detection in blood, plasma, or serum.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Now Diagnostics company profile →
Cempra Logo

Cempra

HQ: United States Website
  • Description: Provider of medicines for the treatment of bacterial infections and chronic illnesses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cempra company profile →
Biotest Pharmaceuticals Logo

Biotest Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceutical and biotherapeutic products utilized in immunology, with innovation in haematology, clinical immunology and intensive care medicine, incorporating innovative technologies and a sharp focus on safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biotest Pharmaceuticals company profile →
Discuva Logo

Discuva

HQ: United Kingdom Website
  • Description: Provider of next-generation antibiotic discovery, Cambridge (UK)-based, established to address major gaps in the treatment of infective disease using proprietary methods, and developer of Ivonescimab (SMT112), a bispecific PD-1/VEGF antibody for oncology in Phase III trials for non-small cell lung cancer and other solid tumors, with over 1,600 patients treated.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Discuva company profile →
Daktari Diagnostics Logo

Daktari Diagnostics

HQ: United States Website
  • Description: Provider of diagnostic medical products for clinicians and patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Daktari Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Isconova

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Isconova

2.2 - Growth funds investing in similar companies to Isconova

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Isconova

4.2 - Public trading comparable groups for Isconova

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Isconova

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Isconova

What does Isconova do?

Isconova is a provider of adjuvants and vaccines, developing and commercializing adjuvants for veterinary and human vaccines to enhance immune reactions with longer duration. Products include Matrix-M, inducing cell- and antibody-mediated immune responses for use in vaccines for humans and dogs.

Who are Isconova's competitors?

Isconova's competitors and similar companies include Now Diagnostics, Cempra, Biotest Pharmaceuticals, Discuva, and Daktari Diagnostics.

Where is Isconova headquartered?

Isconova is headquartered in Sweden.

How many employees does Isconova have?

Isconova has 1,000 employees 🔒.

When was Isconova founded?

Isconova was founded in 2010 🔒.

What sector and industry vertical is Isconova in?

Isconova is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Isconova

Who are the top strategic acquirers in Isconova's sector and industry

Top strategic M&A buyers and acquirers in Isconova's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Isconova?

Top strategic M&A buyers groups and sectors for Isconova include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Isconova's sector and industry vertical

Which are the top PE firms investing in Isconova's sector and industry vertical?

Top PE firms investing in Isconova's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Isconova's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Isconova's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Isconova's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Isconova include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Isconova's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Isconova?

The key public trading comparables and valuation benchmarks for Isconova include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Isconova for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Isconova with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Isconova's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Isconova with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Isconova's' sector and industry vertical?

Access recent funding rounds and capital raises in Isconova's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Isconova